Understanding the interactions between repurposed drugs sertindole and temoporfin with receptor for advanced glycation endproducts: Therapeutic implications in cancer and metabolic diseases
- Authors
- Shamsi, Anas; Shahwan, Moyad; Anwar, Saleha; Ashames, Akram; Khan, Mohd Shahnawaz; Yadav, Dharmendra Kumar
- Issue Date
- Jun-2024
- Publisher
- SPRINGER
- Keywords
- RAGE; Drug repurposing; Sertindole; Temoporfin; Virtual screening; Molecular dynamics simulation; Small molecule inhibitors
- Citation
- JOURNAL OF MOLECULAR MODELING, v.30, no.6
- Journal Title
- JOURNAL OF MOLECULAR MODELING
- Volume
- 30
- Number
- 6
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91673
- DOI
- 10.1007/s00894-024-05967-4
- ISSN
- 1610-2940
0948-5023
- Abstract
- ContextIn the pursuit of novel therapeutic possibilities, repurposing existing drugs has gained prominence as an efficient strategy. The findings from our study highlight the potential of repurposed drugs as promising candidates against receptor for advanced glycation endproducts (RAGE) that offer therapeutic implications in cancer, neurodegenerative conditions and metabolic syndromes. Through careful analyses of binding affinities and interaction patterns, we identified a few promising candidates, ultimately focusing on sertindole and temoporfin. These candidates exhibited exceptional binding affinities, efficacy, and specificity within the RAGE binding pocket. Notably, they displayed a pronounced propensity to interact with the active site of RAGE. Our investigation further revealed that sertindole and temoporfin possess desirable pharmacological properties that highlighted them as attractive candidates for targeted drug development. Overall, our integrated computational approach provides a comprehensive understanding of the interactions between repurposed drugs, sertindole and temoporfin and RAGE that pave the way for future experimental validation and drug development endeavors.MethodsWe present an integrated approach utilizing molecular docking and extensive molecular dynamics (MD) simulations to evaluate the potential of FDA-approved drugs, sourced from DrugBank, against RAGE. To gain deeper insights into the binding mechanisms of the elucidated candidate repurposed drugs, sertindole and temoporfin with RAGE, we conducted extensive all-atom MD simulations, spanning 500 nanoseconds (ns). These simulations elucidated the conformational dynamics and stability of the RAGE-sertindole and RAGE-temoporfin complexes.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91673)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.